Prediagnostic 25-Hydroxyvitamin D,VDRandCASRPolymorphisms, and Survival in Patients with Colorectal Cancer in Western European Populations
- 28 March 2012
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 21 (4), 582-593
- https://doi.org/10.1158/1055-9965.epi-11-1065
Abstract
Background: Individuals with higher blood 25-hydroxyvitamin D [25(OH)D] levels have a lower risk of developing colorectal cancer (CRC), but the influence of 25(OH)D on mortality after CRC diagnosis is unknown. Methods: The association between prediagnostic 25(OH)D levels and CRC-specific (N = 444) and overall mortality (N = 541) was prospectively examined among 1,202 participants diagnosed with CRC between 1992 and 2003 in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Multivariable Cox proportional hazards models were used to calculate HRs and corresponding 95% CIs according to 25(OH)D quintiles and genetic variation within the VDR and CASR genes. Potential dietary, lifestyle, and metabolic effect modifiers were also investigated. Results: There were 541 deaths, 444 (82%) due to CRC. Mean follow-up was 73 months. In multivariable analysis, higher 25(OH)D levels were associated with a statistically significant reduction in CRC-specific (Ptrend = 0.04) and overall mortality (Ptrend = 0.01). Participants with 25(OH)D levels in the highest quintile had an adjusted HR of 0.69 (95% CI: 0.50–0.93) for CRC-specific mortality and 0.67 (95% CI: 0.50–0.88) for overall mortality, compared with the lowest quintile. Except for a possible interaction by prediagnostic dietary calcium intake (Pinteraction = 0.01), no other potential modifying factors related to CRC survival were noted. The VDR (FokI and BsmI) and CASR (rs1801725) genotypes were not associated with survival. Conclusions: High prediagnostic 25(OH)D levels are associated with improved survival of patients with CRC. Impact: Our findings may stimulate further research directed at investigating the effects of blood vitamin D levels before, at, and after CRC diagnosis on outcomes in CRC patients. Cancer Epidemiol Biomarkers Prev; 21(4); 582–93. ©2012 AACR.Keywords
Other Versions
This publication has 47 references indexed in Scilit:
- Serum vitamin D levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort studyBMC Cancer, 2010
- Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2010
- Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancerBritish Journal of Cancer, 2009
- Prospective study of predictors of vitamin D status and survival in patients with colorectal cancerBritish Journal of Cancer, 2009
- Association between serum 25(OH)D and death from prostate cancerBritish Journal of Cancer, 2009
- Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic ReviewJournal of Clinical Oncology, 2008
- Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective StudyBritish Journal of Cancer, 2007
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisPublished by American Medical Association (AMA) ,2006
- Calcium plus Vitamin D Supplementation and the Risk of Colorectal CancerNew England Journal of Medicine, 2006
- Diet and cancer — the European Prospective Investigation into Cancer and NutritionNature Reviews Cancer, 2004